Last reviewed · How we verify

NCT06280430

Vascular Affection in Behcet Disease

Status unknown Last updated 28 February 2024
What this trial tests

trial in Behcet Disease and Vascular Involvement in 90 participants. Status unknown.

Timeline
1 March 2024
Primary endpoint
1 March 2025
1 April 2025

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment90
Start date1 March 2024
Primary completion1 March 2025
Estimated completion1 April 2025

Conditions studied

Sponsor

Assiut University

Who can join

Adults 20 to 45, any sex, with Behcet Disease and Vascular Involvement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To measure the level of serum elafin in patients with behcet disease and to assess the correlation between serum elafin and vascular affection and their relation with disease activity

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06280430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing